Latest Insider Transactions at Ingevity Corp (NGVT)
This section provides a real-time view of insider transactions for Ingevity Corp (NGVT). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Ingevity Corp to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Ingevity Corp's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Apr 28
2023
|
Luis M Fernandez Moreno Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,645
+7.76%
|
-
|
|
Apr 28
2023
|
Jean S Blackwell Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,645
+31.44%
|
-
|
|
Apr 19
2023
|
Mary Dean Hall EVP, Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,576
-3.44%
|
$111,896
$71.85 P/Share
|
|
Apr 03
2023
|
William J Slocum Director |
BUY
Grant, award, or other acquisition
|
Direct |
317
+11.1%
|
$22,507
$71.2 P/Share
|
|
Mar 07
2023
|
Richard Allen White Jr SVP and Pres, Perf Chemicals |
SELL
Open market or private sale
|
Direct |
1,439
-18.06%
|
$116,559
$81.0 P/Share
|
|
Mar 02
2023
|
Stuart Edward Woodcock Jr. EVP, President Perf Materials |
SELL
Open market or private sale
|
Direct |
4,968
-15.77%
|
$407,376
$82.14 P/Share
|
|
Mar 02
2023
|
Phillip John Platt SVP, Finance & CAO |
SELL
Open market or private sale
|
Direct |
8,847
-22.59%
|
$716,607
$81.7 P/Share
|
|
Mar 02
2023
|
Phillip John Platt SVP, Finance & CAO |
BUY
Exercise of conversion of derivative security
|
Direct |
5,858
+15.45%
|
$246,036
$42.02 P/Share
|
|
Feb 28
2023
|
Mary Dean Hall EVP, Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
4,942
+17.66%
|
-
|
|
Feb 28
2023
|
Mary Dean Hall EVP, Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
367
-1.99%
|
$30,094
$82.56 P/Share
|
|
Feb 28
2023
|
Christine Stunyo SVP, Chief HR Officer |
BUY
Grant, award, or other acquisition
|
Direct |
2,035
+16.41%
|
-
|
|
Feb 28
2023
|
Steven Paul Hulme SVP and Pres, APT |
BUY
Grant, award, or other acquisition
|
Direct |
970
+39.74%
|
-
|
|
Feb 28
2023
|
Steven Paul Hulme SVP and Pres, APT |
SELL
Payment of exercise price or tax liability
|
Direct |
98
-16.36%
|
$8,036
$82.56 P/Share
|
|
Feb 28
2023
|
John C. Fortson President & CEO |
BUY
Grant, award, or other acquisition
|
Direct |
19,380
+16.13%
|
-
|
|
Feb 28
2023
|
John C. Fortson President & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
2,400
-1.44%
|
$196,800
$82.56 P/Share
|
|
Feb 28
2023
|
Richard Allen White Jr SVP and Pres, Perf Chemicals |
BUY
Grant, award, or other acquisition
|
Direct |
3,344
+29.56%
|
-
|
|
Feb 28
2023
|
Richard Allen White Jr SVP and Pres, Perf Chemicals |
SELL
Payment of exercise price or tax liability
|
Direct |
237
-2.47%
|
$19,434
$82.56 P/Share
|
|
Feb 28
2023
|
Stacy Cozad EVP, Gen. Counsel & Secretary |
BUY
Grant, award, or other acquisition
|
Direct |
3,758
+20.45%
|
-
|
|
Feb 28
2023
|
Stacy Cozad EVP, Gen. Counsel & Secretary |
SELL
Payment of exercise price or tax liability
|
Direct |
332
-2.97%
|
$27,224
$82.56 P/Share
|
|
Feb 28
2023
|
Stuart Edward Woodcock Jr. EVP, President Perf Materials |
BUY
Grant, award, or other acquisition
|
Direct |
3,453
+9.88%
|
-
|
|
Feb 28
2023
|
Stuart Edward Woodcock Jr. EVP, President Perf Materials |
SELL
Payment of exercise price or tax liability
|
Direct |
727
-1.27%
|
$59,614
$82.56 P/Share
|
|
Feb 28
2023
|
Phillip John Platt SVP, Finance & CAO |
BUY
Grant, award, or other acquisition
|
Direct |
1,538
+15.29%
|
-
|
|
Feb 28
2023
|
Phillip John Platt SVP, Finance & CAO |
SELL
Payment of exercise price or tax liability
|
Direct |
165
-1.16%
|
$13,530
$82.56 P/Share
|
|
Feb 27
2023
|
Erik Spencer Ripple Chief Growth and Innovation Of |
SELL
Payment of exercise price or tax liability
|
Direct |
180
-1.67%
|
$15,660
$87.81 P/Share
|
|
Feb 27
2023
|
John C. Fortson President & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
1,376
-1.62%
|
$119,712
$87.81 P/Share
|
|
Feb 27
2023
|
Richard Allen White Jr SVP and Pres, Perf Chemicals |
SELL
Payment of exercise price or tax liability
|
Direct |
76
-1.54%
|
$6,612
$87.81 P/Share
|
|
Feb 27
2023
|
Stacy Cozad EVP, Gen. Counsel & Secretary |
SELL
Payment of exercise price or tax liability
|
Direct |
294
-2.56%
|
$25,578
$87.81 P/Share
|
|
Feb 27
2023
|
Stuart Edward Woodcock Jr. EVP, President Perf Materials |
SELL
Payment of exercise price or tax liability
|
Direct |
277
-0.95%
|
$24,099
$87.81 P/Share
|
|
Feb 27
2023
|
Phillip John Platt SVP, Finance & CAO |
SELL
Payment of exercise price or tax liability
|
Direct |
57
-0.79%
|
$4,959
$87.81 P/Share
|
|
Feb 17
2023
|
Bruce D. Hoechner Director |
BUY
Grant, award, or other acquisition
|
Direct |
326
+50.0%
|
-
|
|
Feb 16
2023
|
Erik Spencer Ripple Chief Growth and Innovation Of |
SELL
Payment of exercise price or tax liability
|
Direct |
731
-6.34%
|
$65,059
$89.67 P/Share
|
|
Feb 16
2023
|
Erik Spencer Ripple Chief Growth and Innovation Of |
BUY
Grant, award, or other acquisition
|
Direct |
1,417
+10.95%
|
-
|
|
Feb 16
2023
|
Phillip John Platt SVP, Finance & CAO |
SELL
Payment of exercise price or tax liability
|
Direct |
460
-6.0%
|
$40,940
$89.67 P/Share
|
|
Feb 16
2023
|
Phillip John Platt SVP, Finance & CAO |
BUY
Grant, award, or other acquisition
|
Direct |
1,417
+15.6%
|
-
|
|
Feb 16
2023
|
Richard Allen White Jr SVP and Pres, Perf Chemicals |
SELL
Payment of exercise price or tax liability
|
Direct |
530
-9.69%
|
$47,170
$89.67 P/Share
|
|
Feb 16
2023
|
Richard Allen White Jr SVP and Pres, Perf Chemicals |
BUY
Grant, award, or other acquisition
|
Direct |
1,473
+21.22%
|
-
|
|
Feb 16
2023
|
Stuart Edward Woodcock Jr. EVP, President Perf Materials |
SELL
Payment of exercise price or tax liability
|
Direct |
2,241
-7.16%
|
$199,449
$89.67 P/Share
|
|
Feb 16
2023
|
Stuart Edward Woodcock Jr. EVP, President Perf Materials |
BUY
Grant, award, or other acquisition
|
Direct |
5,014
+13.81%
|
-
|
|
Feb 16
2023
|
John C. Fortson President & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
6,080
-3.59%
|
$541,120
$89.67 P/Share
|
|
Feb 16
2023
|
John C. Fortson President & CEO |
BUY
Grant, award, or other acquisition
|
Direct |
19,265
+10.2%
|
-
|
|
Feb 01
2023
|
Stacy Cozad EVP, Gen. Counsel & Secretary |
SELL
Payment of exercise price or tax liability
|
Direct |
1,144
-9.05%
|
$93,808
$82.87 P/Share
|
|
Jan 04
2023
|
William J Slocum Director |
BUY
Grant, award, or other acquisition
|
Direct |
317
+12.49%
|
$22,507
$71.02 P/Share
|
|
Dec 02
2022
|
Erik Spencer Ripple Chief Growth and Innovation Of |
SELL
Open market or private sale
|
Direct |
856
-7.81%
|
$65,912
$77.84 P/Share
|
|
Dec 01
2022
|
Richard Allen White Jr SVP and Pres, Perf Chemicals |
SELL
Open market or private sale
|
Direct |
1,639
-29.09%
|
$126,203
$77.97 P/Share
|
|
Dec 01
2022
|
Richard Allen White Jr SVP and Pres, Perf Chemicals |
BUY
Exercise of conversion of derivative security
|
Direct |
1,639
+22.54%
|
$73,755
$45.04 P/Share
|
|
Nov 01
2022
|
Richard Allen White Jr SVP and Pres, Perf Chemicals |
SELL
Payment of exercise price or tax liability
|
Direct |
360
-8.27%
|
$24,120
$67.97 P/Share
|
|
Oct 03
2022
|
Karen G Narwold Director |
BUY
Grant, award, or other acquisition
|
Direct |
362
+4.09%
|
$22,444
$62.2 P/Share
|
|
Oct 03
2022
|
William J Slocum Director |
BUY
Grant, award, or other acquisition
|
Direct |
362
+15.98%
|
$22,444
$62.2 P/Share
|
|
Sep 06
2022
|
Phillip John Platt SVP, Finance & CAO |
SELL
Payment of exercise price or tax liability
|
Direct |
429
-6.42%
|
$28,314
$66.17 P/Share
|
|
Sep 06
2022
|
Erik Spencer Ripple Chief Growth and Innovation Of |
SELL
Payment of exercise price or tax liability
|
Direct |
511
-4.45%
|
$33,726
$66.17 P/Share
|